What Do Analysts Suggest For EnteroMedics Inc. (ETRM)


EnteroMedics Inc. (ETRM) will report its next earnings on May 16 BMO. The company reported the earnings of $-1.27/Share in the last quarter where the estimated EPS by analysts was $-0.63/share. The difference between the expected and actual EPS was $-0.64/share, which represents an Earnings surprise of -101.6%.

Many analysts are providing their Estimated Earnings analysis for EnteroMedics Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.86/share. These analysts have also projected a Low Estimate of $-0.86/share and a High Estimate of $-0.86/share.

In case of Revenue Estimates, 300000 analysts have provided their consensus Average Revenue Estimates for EnteroMedics Inc. as 1000. According to these analysts, the Low Revenue Estimate for EnteroMedics Inc. is 300 Million and the High Revenue Estimate is 300 Million. The company had Year Ago Sales of 276 Million.

Some buy side analysts are also providing their Analysis on EnteroMedics Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

EnteroMedics Inc. closed its last trading session at $4.2 with the gain of 11.43%. The Market Capitalization of the company stands at 31.68 Million. The Company has 52-week high of $30.41 and 52-week low of $0.04. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.78% where SMA50 and SMA200 are -11.72% and 47.34% respectively. The Company Touched its 52-Week High on 05/23/16 and 52-Week Low on 01/04/17.

The Relative Volume of the company is 6.1 and Average Volume (3 months) is 683.39 million. EnteroMedics Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -196.9%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -786.1%.

While looking at the Stock’s Performance, EnteroMedics Inc. currently shows a Weekly Performance of 2.63%, where Monthly Performance is -13.97%, Quarterly performance is -35.8%, 6 Months performance is 8730.19% and yearly performance percentage is 598.51%. Year to Date performance value (YTD perf) value is 134%. The Stock currently has a Weekly Volatility of 16.63% and Monthly Volatility of 10.70%.